Thyroid dysfunction in patients with chronic hepatitis C before and after interferon therapy;Disfuncion tiroidea en pacientes con hepatitis cronica C pre y post tratamiento con interferon

Revista Espanola de Enfermedades Digestivas

Volumn 88, Issue 7, 1996, Pages 480-484

  Martin Vivaldi R ^a   Nogueras, F ^a,b   Quintero, D ^a   Espinosa, M D ^a   Lopez De Hierro, M ^a   Suarez J F ^a   Gonzalez A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b NONE   (Spain)

Author keywords

chronic hepatitis C; interferon therapy; thyroid dysfunction

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; ANTIVIRUS AGENT; THYROXINE;

ADULT; ANTIBODY TITER; ARTICLE; CHRONIC HEPATITIS; FEMALE; HEPATITIS C; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; THYROID DISEASE; THYROID FUNCTION; CHEMICALLY INDUCED DISORDER; MIDDLE AGED;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; HYPOTHYROIDISM; INTERFERON-ALPHA; INTERFERON-BETA; MALE; MIDDLE AGED; THYROXINE;

EID: 0030183753     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM y Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 1992; 102: 2155-2160.
2. Watanabe U, Hashimoto E, Hisamitsu T, Obata H y Hayashi N. The risk factor for development of thyroid disease during interferon-α therapy for chronic hepatitis C. Am J Gastroenterol 1994; 89: 399-403.
3. Rönnblom LE, Alm GB y Öberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 115: 178-183.
4. Primo J, Martínez C, Miralles A et al. Desarrollo de disfunción tiroidea en pacientes con hepatitis crónica C tratados con interferon alfa. Gastroenterología y Hepatología 1993; 16: 593-598.
5. Kung AWC, Jones BM y Lai CL. Effects of interferon-α therapy on thyroid function, T lymphocyte subpopulations and induction of autoantibodies. J Clin Endocr Metab 1990; 71: 1230-1234.
6. Maccari S, Bassi C, Giovannini AG y Plancher. A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy. Clin Rheumatol 1991; 10: 452-454.
7. Papo T, Marcellin P, Bernuau J, Durand F, Poynard T y Benhamou JP. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 1992; 116: 51-53.
8. Akard LP, Hoffman R, Elias L y Saiers JH. Alpha-interferon and immune hemolytic anemia. Ann Intern Med 1986; 105: 306.
9. Chung YH y Shong YK. Development of thyroid autoimmunity after administration of recombinant human interferonα 2b for chronic viral hepatitis. Am J Gastroenterol 1993; 88: 244-247.
10. Gisslinger H, Gilly B, Woloszczuk W et al. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol 1992; 90: 363-367.
11. Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL y Clark JW. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990; 65: 2237-2242.
12. Eugène C, Tennenbaum R, Anciaux ML, Quevauvilliers J y Bergue A. Dysthyroïdies auto-immunes induites par l'interféron alpha chez 2 femmes atteintes d'hépatite chronique non-A, non-B. Gastroenterol Clin Biol 1993; 17: 594-597.
13. Marcellin P, Pouteau M, Renard P et al. Sustained hypothyroidism induced by recombinant a interferon in patients with chronic hepatitis C. Gut 1992; 33: 855-856.
14. Marcellin P, Pouteau M, Baudin E et al. Thyroid dysfunction induced by recombinant alpha interferon in patients with chronic hepatitis C: a prospective study. Hepatology 1991, 14: 77A.
15. Rumi MG, Marcelli R, La Rosa L et al. High prevalence of thyroid dysfunction in patients with HCV infection treated with interferon alpha 2a (IFN). Hepatology 1992; 16: 219A.
16. Schultz M, Müller R, Von zur Mühlen A y Brabant G. Induction of hyperthyroidism by interferon-α-2b. Lancet 1989; 1: 1452.
17. Tran A, Quarante JF, Benzaken S et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993; 18: 253-257.
18. Pateron D, Hartmann DJ, Duclos-Vallee JC, Jouanolle H y Beaugrand M. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 1992; 16: 244-245.
19. Pateron D, Hartmann DJ, Duclos-Vallée JC, Jouanolle H y Beaugrand M. High prevalence of abnormal thyroid tests in patients with chronic hepatitis C (CHC) before alpha interferon (IFN) therapy: relation with IFN induced thyroid dysfunction. Hepatolooy 1991; 14: 77A.
20. Primo J, Hinojosu J, Molés JR et al. Development of thyroid dysfunction after α-interferon treatment of chronic hepatitis C. Am J Gastroenterol 1993; 88: 1976-1977.
21. Berris B y Feinman SV. Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis. Dig Dis Sci 1991; 36: 1657-1660.
22. Tunbridge WMG y Caldwell G. The epidemiology of thyroid diseases. En: The thyroid: a fundamental and clinical text, de Braverman LE y Utiger RD. Lippincott. Philadelphia, 1991; 578-587.
23. Pagliacci MC, Pelicci G, Schippa M, Liberati AM y Nicoletti I. Does interferon-β therapy induce thyroid autoimmune phenomena? Horm Metab Res 1991; 23: 196-197.
24. Picciotto A, Varagona G, Cianciosi P, Franceschini R, Garibaldi A y Celle G. Thyroid function and Interferon treatment in chronic hepatitis C. Gut 1993; 34: 574.
25. Marcellin P, Pouteau M, Linhart N, Bok B y Benhamou JP. Thyroid function and interferon treatment in chronic hepatitis C. Gut 1993; 34: 574.
26. Quaranta JF, Tran A, Régnier D et al. High prevalence of antibodies to hepatitis C virus (HCV) in patients with antithyroid autoantibodies. J Hepatol 1993; 18: 136-138.
27. Saracco G, Touscoz A, Durazzo M et al. Autoantibodies and response to α-interferon in patients with chronic viral hepatitis. J Hepatol 1990; 11: 339-343.